Clinical Trial

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium - Maintenance

Name: Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium - Maintenance — clinical trial record (NCT07684794)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RESONATE-M

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif XCS System when used as indicated for treatment-resistant depression (TRD).

Trial Details

NCT Number	NCT07684794
Lead Sponsor	Motif Neurotech, Inc.
Conditions	Major Depressive Disorder (MDD)
Enrollment	10 participants
Start Date	2026-08-10
Primary Completion	2026-11-01 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-06